Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Concise guidance on identifying budgeting flaws early and applying simple corrections to avoid debt and build security.
24,706 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Mustafa Abbasi has been named president and takes the helm at Sotheby’s Canada, signaling a tech-forward push for gro...
The SEC will host an April roundtable on options market structure, focusing on how bitcoin exposure sits inside regul...
AI-driven demand and easing supply bottlenecks push chipmakers into the spotlight. Here’s a timely look at the best s...
A fresh cash bid for Two Harbors Investment Corp. sparks a renewed bidding war, putting pressure on UWM to top terms ...
Southwest Airlines CEO Bob Jordan is taking a bold step to reclaim time for real work by blocking Wednesday through F...
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
XRP has long been tied to a grand bridge-currency dream. This article presents a bull case that even skeptics should ...
When Warren Buffett's successor Greg Abel took the helm, Berkshire Hathaway signaled a new phase. This article breaks...
iren’s just said words have become a shorthand for the next big hurdle in AI infrastructure: securing reliable power ...
Micron Technology surged to a market value near $1.19 trillion on June 2, 2026, closing in on Meta Platforms. The ral...
U.S. lenders are accelerating cash returns to shareholders after stress tests and capital rules ease. JPMorgan, Bank ...